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Abstract: Background: The aim of this study was to assess diagnostic accuracy and reliability of
narrow band imaging (NBI) in the differential diagnosis of laryngeal premalignant lesion, early
cancers and recurrences. Material and methods: We enrolled 231 patients who underwent endoscopic
examination with white light endoscopy (WLE) + NBI and divided them into two groups, group
A, without previous radiochemotherapy and group B, with previous radiochemotherapy. When
indicated, we performed surgical biopsies to evaluate sensitivity, specificity, positive predictive
value (PPV), negative predictive value (NPV), accuracy and likelihood of endoscopic examination
comparing WLE alone and WLE + NBI. Results: A positive NBI lesion, compared with a negative NBI
lesion, had a 29.68 (group A) and 13.96 (group B) times higher probability to be histologically positive
(i.e., confirmed) compared with WLE alone improving the diagnostic accuracy. In group A, the NBI
mode showed excellent sensitivity (95.0%), which was higher than WLE 2 mode (77.5%). However,
the greatest differences were recorded regarding specificity (96.8% vs. 40.6%). In group B, both NBI
alone and WLE + NBI mode showed a 94.1% specificity compared with WLE alone, which had a
maximum specificity of 85.3%. The mode comparison between NBI and WLE in both groups showed
a statistically significant difference, with p-values <0.0001. Conclusions: NBI represents a reliable
technology in challenging situations, especially in the context of post-radiotherapy or post-surgical
mucosal changes showing a high NPV. NBI could reduce the number of unnecessary biopsies related
to increased microvascular anomaly revelation, which could help to identify early-stage lesions
suitable for minimally invasive surgery and, consequently, decrease hospital admissions.
Keywords: narrow band imaging; larynx; head and neck cancer
1. Introduction
The mucosal surface of the upper aerodigestive tract (UADT) is an onset site of several
pathologies with different etiology, pathogenesis and clinical presentation. Moreover, the
UADT epithelium of the nasal and oral mucosa to the hypoglottic larynx shows pathologi-
cal peculiarities, thus representing a challenging tract to explore. Considering that benign
and malignant lesions represent some of the most frequent pathologies examined by the
otolaryngologist, in the last decades a lot of new techniques were developed to examine
the UADT [1]. Nowadays, the tract can be easily explored with traditional endoscopic
techniques, but several studies and improvements in the endoscopic sector took place in
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the last years which increase diagnostic precision with simple and reliable equipment [2,3].
In fact, currently available diagnostic tools, including traditional endoscopes equipped
with white light, are insufficient to unequivocally assess observed pathologies of the oral
and laryngeal mucosa, hampering differential diagnosis of early neoplastic lesions and the
extent of tumor infiltration [4]. In the last years, one of the most innovative and useful tech-
nologies is narrow-band imaging (NBI). NBI is an endoscopic optical imaging technique
to enhance mucosal surface texture contrast and visualization of mucosal and submu-
cosal vasculature increasing the diagnostic sensitivity on surface lesions or neoangiogenic
patterns, which cannot be detected by regular white light endoscopy (WLE) [1]. NBI is
based on the different light-absorbing properties of blood and mucosa; at this purpose,
NBI filters produce only blue (415 nm of wavelength) and green (540 nm of wavelength)
light, which visualize with different depth the mucosa, coloring superficial and submu-
cosal vessels brown. This technology allows the clinician to assess the vascularization of
mucosal lesions, increasing the diagnostic accuracy of traditional high-definition video
laryngoscopy. NBI already showed its usefulness in early diagnosis of neoplastic lesions
of the UADT [2–5] and in 2011, Ni et al. [6] proposed a classification based on the modifi-
cation of mucosal vascularization observed with NBI allowing the in vivo differentiation
of non-malignant and malignant laryngeal lesions. Furthermore, NBI is widely used for
inflammatory pathologies of the head and neck in all age groups [7,8]. However, a precise
diagnosis of mucosal lesions remains challenging and recent studies aimed at assessing
its diagnostic accuracy in laryngeal lesions [9,10]. Considering the wide application of
NBI in the head and neck area and the difficulties encountered by the physician with the
number of different pathologies affecting these structures, the aim of our study was to
assess the accuracy of NBI based on the differential diagnosis of laryngeal premalignant
lesion, early cancers and tumor recurrences after radiotherapy in a large case series and
single institution. Particular attention was paid to the negative predictive value (NPV)
to assess its value in reducing numbers of surgical biopsies, especially in patients with
unfavorable clinical conditions.
2. Materials and Methods
2.1. Design of the Study and Population
This was a single-center retrospective observational study carried out, between Jan-
uary 2017 and May 2019, in an Otorhinolaryngology unit at the Fondazione Policlinico
Universitario Agostino Gemelli IRCCS in Rome (Italy). All outpatients who underwent
a high-magnifying transnasal endoscopy with NBI technology as part of their physical
examination, and patients older than 18 years affected by a macroscopic lesion of laryngeal
mucosa, with endoscopic signs of cancer transformation or precancerous characteristics,
were included. Patients who received diagnosis of benign lesions (such as laryngeal polyps,
cysts, Reinke’s edema or vocal nodules), without signs of hyperkeratosis or papillomato-
sis, were excluded. We divided patients into two groups: patients without previous
radiochemotherapy treatment (group A) and patients with previous radiochemotherapy
treatment for laryngeal cancer (group B).
2.2. Instruments and Endoscopic Evaluation
Our outpatient clinic is equipped with a video rhinolaryngoscope and built-in NBI
technology (CV-170; Olympus Medical System, Tokyo, Japan). The endoscopic examination
was performed by a single experienced otolaryngologist with the patient in supine position.
During the exam, a button allowed switching from white light endoscopy (WLE) to NBI.
Ecocain®, (Molteni Dental srl, Milan, Italy) Lidocaine, 10 g/mL; dose: 2 sprays was
administered 15 min before the procedure. Transnasal endoscopic images were reproduced
on a 1080 p monitor and all exams were recorded for remote replay and review by a second
examiner. Lesions assessed in WLE were classified as benign (0), uncertain (1) or clearly
malignant (2), depending on the opinion of each examiner. Using NBI, laryngeal lesions
were categorized according to the classifications proposed by Ni et al. [6] as follows: (0)
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non-malignant (pattern type I and II); (1) suspected leucoplakia and high-grade dysplasia
or carcinoma (pattern type III, IV and V). In case of concordance between diagnoses of
the two examiners, the lesion was classified as described. In case of disagreement, both
examiners reviewed the video of the endoscopy again and a joint diagnosis was expressed.
2.3. Diagnostic Procedures
According to our clinical practice, if necessary and if patients’ clinical status allowed
it, after endoscopic evaluation a biopsy of the lesion was planned; otherwise, patients
were sent to close follow-up. Laryngeal biopsy in the operating room was foreseen by
means of a surgical procedure under general anesthesia, using an operative microscope.
Tissue samples were formalin-fixed and paraffin-embedded, then examined by a single
expert pathologist. The histopathological evaluation was performed according to WHO
classification as follows: benign lesion (0), low-grade dysplasia (1), high grade dysplasia
(2), carcinoma in situ or invasive (3) [11]. Depending on histology, lesions classified as
high-grade dysplasia (2) and carcinoma in situ or invasive (3) were considered positive,
while lesions classified as benign lesions (0) and low-grade dysplasia (1) were consid-
ered negative.
2.4. Statistical Analysis
We evaluated sensitivity, specificity, positive predictive value (PPV), negative predic-
tive value (NPV), accuracy, likelihood ratios and area under the ROC (Receiver Operating
Characteristic) curves (AUC) in the following four modalities, according to possible diag-
nosis combinations:
1. NBI: lesions classified in NBI, suspected as high-grade dysplasia or carcinoma (1),
were considered as positive; lesions classified as non-malignant (0) as negative.
2. WLE 1 + 2: lesions classified in WLE as uncertain (1) or clearly malignant (2) were
considered positive; lesions classified as benign (0) as negative.
3. WLE 2: only lesions classified in WLE as clearly malignant (2) were considered
positive; lesions classified as benign (0) or as uncertain (1) were considered negative.
4. WLE 1 + 2 + NBI: lesions classified in NBI, suspected as high-grade dysplasia or
carcinoma (1), and at the same time classified in WLE as uncertain (1) or clearly
malignant (2) were considered as positive; lesions classified in white light as benign
(0) or classified in NBI as non-malignant (0) were considered as negative.
In addition, lesions for which no biopsy was performed, and which were stable or
completely regressed after an endoscopic follow-up every 3 months for more than 18
months, were included in the statistical calculation as negative biopsies. An SPSS Statistics
version 24 (IBM) database was used for statistical analysis. We used Chi-square test and
ROC curves, and for the four modes listed above, AUC was also calculated, with the
respective 95% confidence intervals.
3. Results
Between January 2017 and December 2019, 958 endoscopic examinations with
WLE + NBI were performed at our institution, among which 196 patients met our inclusion
criteria as they presented a macroscopic laryngeal lesion with suspicious endoscopic signs
or potentially malignant transformation. One hundred and forty-five patients out of 196
(74.0%) were male and had a mean age of 60.5 ± 12.3 (range 26–93).
Group A included 156 out of 196 (79.6%) patients and 39 patients showed more than
one lesion, for a total of 195 lesions. Group B included 40 out of 196 (20.4%) patients and
11 patients showed more than a single lesion, for a total of 51 lesions (Table 1).
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Sex (M–F) 145–51 112–39 33–12
Pts with >1 lesion 50 39 11
Total lesions 246 195 51
F: female; M: male; Pts: patients; SD: Standard Deviation.
3.1. Group A
Surgical biopsies were indicated and performed in 70 out of 195 (35.9%) lesions.
Histology of Group A resulted as follows:
• benign (0), n = 25 (35.7%) (Figure 1)
• low-grade dysplasia (1), n = 5 (7.1%)
• high-grade dysplasia (2), n = 12 (17.1%)
• carcinoma in situ or invasive (3), n = 28 (40.1%)
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Figure 1. Patient, 63 years old with hyperkeratosic lesions, stable at three year close follow up. 
WLE endoscopy (a), NBI examination (b). 
Figure 1. Patient, 63 years old with hyperkeratosic lesio s, sta le at t ree ear cl se f ll . WLE
endoscopy (a), NBI examination (b).
We also included six stable and one regressed lesion at follow-up as negative biopsies
(mean follow-up of 23.33 ± 3.14 months). The values of sensitivity, specificity, PPV, NPV,
accuracy and likelihood were then calculated and are shown in Table 2. The ROC curve
(Figure 2) summarizes the comparison between the different modes. In group A, the
NBI mode showed excellent sensitivity (95.0%), which was higher than the WLE 2 mode
sensitivity (77.5%) and equal to WLE 1 + 2 mode sensitivity (95.0%). However, the greatest
differences were recorded regarding specificity; NBI and WLE 1 + 2 + NBI showed a 96.8%
and 94.2% specificity respectively, while in WLE 1 + 2 the specificity dropped to 40.6%. We
observed also clear differences regarding the PPV (88.3% vs. 29.2%) and accuracy (96.4%
vs. 51.8%) comparing NBI and WLE 1 + 2 modes. Finally, AUC summarizes the results
described above, with excellent values for NBI (0.96, 95% CI 0.91–0.99) and WLE 1 + 2 +
NBI (0.92, 95% CI 0.86–0.97), and significantly poorer accuracy in the WLE 1 + 2 mode (0.67,
95% CI 0.59–0.75).
No biopsy was performed in 125 out of 195 (64.1%) lesions and patients were followed
up endoscopically; moreover, seven lesions were present after biopsy, for a total of 132
lesions addressed to follow-up. After a mean follow-up of 12.21 ± 4.63 months, two out
of 132 (1.5%) lesions progressed to carcinoma and one out of 132 (0.7%) to high-grade
dysplasia.
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Table 2. Sensitivity, specificity, positive predictive value (PPV), positive negative value (PNV), accuracy, likelihood ratio
and comparison of area under the ROC curves (AUC) of the four diagnostic modalities in group A.
Indicator NBI WLE 1 + 2 WLE 2 WLE 1 + 2 and NBI
Sensitivity 95.0 % 95.0 % 77.5 % 90.0 %
Specificity 96.8 % 40.6 % 89.0 % 94.2 %
PPV 88.3 % 29.2 % 64.6 % 80.0 %
NPV 98.7 % 96.9 % 93.9 % 97.3 %
Accuracy 96.4 % 51.8 % 86.7 % 93.3 %
Positive likelihood ratio 29.68 1.59 7.04 15.51
Negative likelihood ratio 0.05 0.13 0.25 0.10
Mode Area Lower limit 95% CI Upper limit 95% CI p
NBI 0.96 0.91 0.99 <0.0001
WLE 1 + 2 0.67 0.59 0.75 <0.0001
WLE 2 0.83 0.75 0.91 <0.0001
WLE 1 + 2 and NBI 0.92 0.86 0.97 <0.0001
Mode comparison z Lower limit 95% CI Upper limit 95% CI p
WLE 1 + 2 vs. WLE 2 −4.168 −0.227 −0.082 <0.0001
WLE 1 + 2 vs. NBI −8.699 −0.344 −0.217 <0.0001
WLE 1 + 2 vs. WLE + NBI −6.608 −0.315 −0.171 <0.0001
WLE 2 vs. NBI −3.420 −0.0199 −0.054 <0.001
WLE 2 vs. WLE + NBI −2.091 −0.171 −0.006 0.037
NBI vs. WLE + NBI 2.040 0.001 0.074 0.041
CI: confidence interval; NBI: narrow band imaging; NPV: negative predictive value; PPV: positive predictive value; WLE: white light
endoscopy.
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3.2. Group B 
Surgical biopsies were indicated and performed in 29 out of 51 (56.9%) lesions of 
group B. The histological examination of group B gave the following results: 
• benign (0), n = 8 (27.6%) 
• low-grade dysplasia (1), n = 4 (13.8%) (Figure 3) 
i r . Receiver operating curve (ROC) and area under the curve (AUC) of the four modalities
analyzed for group . olors of the curves: reen: narro -band i aging (NBI); Orange: white light
endoscopy (WLE) 1 + 2 + NBI; Red: WLE 2; Blue: WLE 1 + 2; Yellow: mean values.
. . ro
r ic l i sies er i i te rf r e i t f ( . ) l i f
r . e ist l ical e a i ati f r a e t e f ll i res lts:
• benign (0), n 8 (27.6 )
• low-grade dysplasia (1), n = 4 (13.8%) (Figure 3)
• high-grade dysplasia (2), n = 6 (20.7%)
• carcinoma in situ or invasive (3), n = 11 (37.9%)
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NBI 0.88 0.78 0.98 <0.0001 
WLE 1 + 2 0.58 0.47 0.69 <0.0001 
WLE 2 0.75 0.62 0.88 <0.0001 
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3. Patient, 65 years old, wi h histo of laryngeal quamous cell carcinoma treated with
chemoradiotherapy. Endoscopic appearance at one year follow-up. White light endoscopy (WLE) (a),
Narrow band imaging (NBI) examination (b). Post-attinic microvascular alterations were suspicious
for dysplasia and confirmed at histopathological exam.
In addition, we included two stable and one regressed lesion at follow-up as “negative”
biopsies (mean follow-up of 21.5 ± 3.5 months). Table 3 resumes the values of sensitivity,
specificity, PPV, NPV, accuracy and likelihood. The ROC curve summarizes the comparison
between the different modes (Figure 4). In group B, the NBI mode showed a higher
sensitivity (82.4%) compared to the WLE 2 mode (64.7%), but slightly lower compared
to the WLE 1 + 2 mode (88.3%). The greatest differences were recorded about specificity:
NBI and WLE 1 + 2 + NBI showed a value of 94.1%, while in WLE 1 + 2 the specificity
dropp d to 29.4%. We bserved also clear differences regarding the PPV (87.5% vs. 38.4%)
and accuracy (90.2% vs. 49.0%) comparing NBI with WLE 1 + 2 modes. Finally, AUC
summarizes the results described above with good values obtained for NBI (0.88, 95% CI
0.78–0.98) and WLE 1 + 2 + NBI (0.85, 95% CI 0.74–0.96). WLE 1 + 2 + NBI mode showed
excellent values, while the data of the WLE 1 + 2 mode (0.58, 95% CI 0.47–0.69) were
significantly lower, with the lower limit of the 95% CI below the value of 0.5. No biopsy
was performed in 22 out of 51 (43.1%) lesions and patients were followed up endoscopically;
moreover, seven lesions were still present after biopsy, for a total of 29 lesions addressed
to follow-up. After a mean follow-up of 14.87 ± 4.11 months, 6 out of 29 (20.7%) lesions
progressed to carcinoma and 1 out of 29 (3.4%) to high-grade dysplasia.
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analyzed for group B. Colors of the curves: Green: NBI; Orange: WLE 1 + 2 + NBI; Red: WLE 2; Blue:
LE 1 + 2; Yellow: mean values.
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Table 3. Sensitivity, specificity, positive predictive value (PPV), positive negative value (PNV), accuracy and likelihood ratio
of the four diagnostic modalities applied in group B.
Indicator NBI WLE 1 + 2 WLE 2 WLE 1 + 2 and NBI
Sensitivity 82.4 % 88.3 % 64.7 % 76.5 %
Specificity 94.1 % 29.4 % 85.3 % 94.1 %
PPV 87.5 % 38.4 % 68.7 % 86.7 %
NPV 91.4 % 83.3 % 82.8 % 88.9 %
Accuracy 90.2 % 49.0 % 78.4 % 88.2 %
Positive likelihood ratio 13.96 1.25 4.40 12.97
Negative likelihood ratio 0.18 0.40 0.41 0.25
Mode Area Lower limit 95% CI Upper limit 95% CI p
NBI 0.88 0.78 0.98 <0.0001
WLE 1 + 2 0.58 0.47 0.69 <0.0001
WLE 2 0.75 0.62 0.88 <0.0001
WLE 1 + 2 and NBI 0.85 0.74 0.96 <0.0001
Mode comparison z Lower limit 95% CI Upper limit 95% CI p
WLE 1 + 2 vs. WLE 2 −2.365 0.347 −0.296 0.018
WLE 1 + 2 vs. NBI −3.714 0.330 −0.449 <0.0001
WLE 1 + 2 vs. WLE + NBI −3.674 0.335 −0.406 <0.0001
WLE 2 vs. NBI −1.842 0.342 −0.273 0.066
WLE 2 vs. WLE + NBI −1.532 0.348 −0.235 0.126
NBI vs. WLE + NBI 1.000 0.322 −0.028 0.317
CI: confidence interval; NBI: narrow band imaging; NPV: negative predictive value; PPV: positive predictive value; WLE: white light
endoscopy.
4. Discussion
The results of the present study showed improved diagnostic accuracy of NBI during
videolaryngoscopy compared with WLE alone in both groups (A and B). In fact, the
probability of a positive NBI lesion compared with a negative NBI lesion, was 29.68
(group A) and 13.96 (group B) times higher to be histologically positive.
The results obtained in group A are in accordance with those reported in literature with
a similar cohort of patients [1,9,10]. In particular, Vilaseca et al. [1] showed that accuracy
improved from 74.1% with WLE to 88.9% with NBI and demonstrated additionally, a better
PPV (NBI: 89% vs. WLE: 74%). In addition, Popek et al. [9] showed a PPV of 97.7% for NBI
vs. 79.6% for WLE.
More interesting are the results of group B compared with data present in litera-
ture. Piazza et al., performed two studies [12,13] about the endoscopic evaluation of
patients in post-radiotherapy follow-up with NBI, enrolling respectively 59 and 183 pa-
tients. Zabrodsky et al. [14] evaluated with NBI endoscopy 66 patients previously treated
with radiotherapy for head and neck cancer, including 85% with laryngeal neoplasm—a
patient cohort easily comparable with group B of our study. Even though, at first sight,
our results demonstrate lower sensitivity and specificity values for NBI compared with
the above-mentioned studies, it is necessary to consider factors that could have influenced
the results of the studies. For example, among the limitations stated in Piazza et al.’s [13]
studies was that they considered lesions without performing biopsy as “true negatives”
despite the short duration of follow-up; in the second study [12] each patient, at least
twice endoscopically evaluated, was considered true negative; however, this assumption
could be insufficient to obtain reliable values of specificity and NPV. Similarly to our
study, Zabrodsky et al. [14] considered persistently negative endoscopy, with an average
follow-up duration of 10 months (range 5–24 months) as true negative. In our study, on
the other side, we considered the lesions of group B without biopsy after a mean follow-
up of 21.5 ± 3.5 months as negative biopsies. In this regard, it should be emphasized
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that to date in literature no reliable indications regarding adequate follow-up duration
are recommended.
Moreover, the differences between the results of group A and group B appear evident.
The reasons for this discrepancy should be ascribed to the difficulty of interpreting endo-
scopic data in patients who underwent previous radiotherapy, as already reported in the
above-mentioned articles. In our opinion, the great inhomogeneity between treated (with
history of radiotherapy) and untreated patients (without history of radiotherapy), may
reduce the clinical relevance of sensitivity, specificity, PPV, NPV and diagnostic accuracy
data of NBI technology, if not separately studied.
Finally, data analysis, concerning progression rate to carcinoma, showed a difference
between the two groups, even though not statistically significant. This trend may represent
a future field of research to evaluate the appropriateness of follow-up attitudes in the
two groups.
The strength of our study are the large cohort and the division in two groups con-
sidering previous radiotherapy treatment. Several studies reported similar results, for
nasopharynx, hypopharynx or larynx [15–17]. Our results present “real-life” data assessing
NBI technology. It represents a useful tool for daily clinical practice, in which we ana-
lyze mucosal lesions on different sites of the head and neck, considering that NBI is a
standardized technique for all of them [6,15,18].
However, some limitations of our study should be mentioned. The duration of the
study (average: 29 months) represented a limitation as only for 10 patients (seven in group
A and three in group B) persistent negativity, as a negative biopsy, could be considered;
therefore, to confirm data, the follow-up period should be extended. In fact, a study by
Zhang et al. [19] suggests that patients with high-grade dysplasia should be followed up
during the first three years, a period in which most malignant lesions generally progress.
Another potential limitation, when evaluating the performance of the NBI, is that the filter
is never used alone, but always after white light mode or alternation. A study protocol
comparing the diagnostic capacity of NBI and WLE individually could precisely define
the diagnostic accuracy of each method. Nevertheless, the use of NBI in association with
WLE, as reported in our study and in literature, guarantees a more realistic assessment
of its performance in daily clinical practice. Another feature that should be considered is
the potential role of the learning curve, which was found to be the leading cause of false
positives in the work conducted by Tirelli et al. [20]. Furthermore, this technology could
have a positive impact on health care costs. In fact, detailed NBI endoscopic examination
could reduce the number of unnecessary biopsies and identify early-stage lesions suitable
for minimally invasive surgery, which could decrease hospital admissions.
5. Conclusions
Early diagnosis of laryngeal neoplasms remains a priority in otolaryngology with
significant therapeutic and prognostic consequences. The technological evolution allows
gaining additional information about biological characteristics to diagnose lesions, which
cannot be obtained with traditional methods. Our high NPV demonstrates that NBI
technology, which is capable of a detailed topographical definition of the lesion enhancing
visualization of microvascular anomalies, represents a reliable instrument in challenging
situations, especially in the context of post-radiotherapy or post-surgical mucosal changes.
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